Taiwan · Delayed Price · Currency is TWD Prince Pharmaceutical Statistics
Total Valuation
TPEX:6935 has a market cap or net worth of TWD 1.12 billion. The enterprise value is 1.39 billion.
| Market Cap | 1.12B |
| Enterprise Value | 1.39B |
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6935 has 36.61 million shares outstanding. The number of shares has increased by 0.63% in one year.
| Current Share Class | 36.61M |
| Shares Outstanding | 36.61M |
| Shares Change (YoY) | +0.63% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 5.77% |
| Owned by Institutions (%) | 12.50% |
| Float | 13.43M |
Valuation Ratios
The trailing PE ratio is 11.72.
| PE Ratio | 11.72 |
| Forward PE | n/a |
| PS Ratio | 1.06 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | 15.60 |
| P/OCF Ratio | 12.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.06, with an EV/FCF ratio of 19.35.
| EV / Earnings | 14.43 |
| EV / Sales | 1.32 |
| EV / EBITDA | 8.06 |
| EV / EBIT | 12.53 |
| EV / FCF | 19.35 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.81 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 2.45 |
| Debt / FCF | 5.88 |
| Interest Coverage | 11.57 |
Financial Efficiency
Return on equity (ROE) is 12.34% and return on invested capital (ROIC) is 9.20%.
| Return on Equity (ROE) | 12.34% |
| Return on Assets (ROA) | 4.86% |
| Return on Invested Capital (ROIC) | 9.20% |
| Return on Capital Employed (ROCE) | 9.29% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | 5.03M |
| Profits Per Employee | 458,671 |
| Employee Count | 210 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 4.78 |
Taxes
In the past 12 months, TPEX:6935 has paid 8.42 million in taxes.
| Income Tax | 8.42M |
| Effective Tax Rate | 8.04% |
Stock Price Statistics
The stock price has increased by +39.95% in the last 52 weeks. The beta is 0.71, so TPEX:6935's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +39.95% |
| 50-Day Moving Average | 28.95 |
| 200-Day Moving Average | 28.86 |
| Relative Strength Index (RSI) | 57.65 |
| Average Volume (20 Days) | 55,300 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6935 had revenue of TWD 1.06 billion and earned 96.32 million in profits. Earnings per share was 2.61.
| Revenue | 1.06B |
| Gross Profit | 222.55M |
| Operating Income | 110.87M |
| Pretax Income | 104.74M |
| Net Income | 96.32M |
| EBITDA | 163.60M |
| EBIT | 110.87M |
| Earnings Per Share (EPS) | 2.61 |
Balance Sheet
The company has 152.62 million in cash and 422.03 million in debt, with a net cash position of -269.41 million or -7.36 per share.
| Cash & Cash Equivalents | 152.62M |
| Total Debt | 422.03M |
| Net Cash | -269.41M |
| Net Cash Per Share | -7.36 |
| Equity (Book Value) | 838.68M |
| Book Value Per Share | 22.91 |
| Working Capital | 250.98M |
Cash Flow
In the last 12 months, operating cash flow was 90.06 million and capital expenditures -18.24 million, giving a free cash flow of 71.81 million.
| Operating Cash Flow | 90.06M |
| Capital Expenditures | -18.24M |
| Depreciation & Amortization | 61.61M |
| Net Borrowing | -40.51M |
| Free Cash Flow | 71.81M |
| FCF Per Share | 1.96 |
Margins
Gross margin is 21.07%, with operating and profit margins of 10.50% and 9.12%.
| Gross Margin | 21.07% |
| Operating Margin | 10.50% |
| Pretax Margin | 9.92% |
| Profit Margin | 9.12% |
| EBITDA Margin | 15.49% |
| EBIT Margin | 10.50% |
| FCF Margin | 6.80% |
Dividends & Yields
TPEX:6935 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.63% |
| Shareholder Yield | -0.63% |
| Earnings Yield | 8.60% |
| FCF Yield | 6.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6935 has an Altman Z-Score of 2.09 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.09 |
| Piotroski F-Score | 7 |